Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD
Clinical trial NCT07184853 · RECRUITING
Trial details
- NCT number
- NCT07184853
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-25
- Primary completion
- 2027-09-25
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.